Corbus Pharmaceuticals Holdings (CRBP) Enterprise Value (QoQ) (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Enterprise Value (QoQ) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.92% |
| Sep 30, 2025 | 77.45% |
| Jun 30, 2025 | -495.78% |
| Mar 31, 2025 | 86.68% |
| Dec 31, 2024 | -630.74% |
| Sep 30, 2024 | 86.17% |
| Jun 30, 2024 | -2,618.98% |
| Mar 31, 2024 | 46.98% |
| Dec 31, 2023 | 49.25% |
| Sep 30, 2023 | 44.08% |
| Jun 30, 2023 | 21.23% |
| Mar 31, 2023 | -1,006.33% |
| Dec 31, 2022 | 93.96% |
| Sep 30, 2022 | 4.45% |
| Jun 30, 2022 | -427.73% |
| Mar 31, 2022 | 85.55% |
| Dec 31, 2021 | -143.62% |
| Sep 30, 2021 | 63.63% |
| Jun 30, 2021 | -2,647.51% |
| Mar 31, 2021 | 95.65% |